Back to search

Article

Topical application of Cas9 ribonucleoproteins inhibits corneal neovascularization in a mouse model of alkali burn injury

2025-07-25

Abstract excerpt

<title>Abstract</title> <p> Corneal neovascularization is a sight-threatening condition for which current treatments such as anti-VEGF agents are limited by invasiveness and side effects. We present the first non-viral, CRISPR/Cas9-based gene therapy delivered via topical eye drops that penetrates the cornea and inhibits pathological neovascularization. Cas9 ribonucleoproteins (RNPs) targeting the <italic>Vegfa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3bbb56b5-2304-55bc-be8a-0125a9b7dd1b
DOI
10.21203/rs.3.rs-7096816/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Topical application of Cas9 ribonucleoproteins inhibits corneal neovascularization in a mouse model of alkali burn injuryDOI 10.21203/rs.3.rs-7096816/v1
Select a neighboring publication to make it the new centre.